Related Experiment Videos
[The somatotropic hormone and liver diseases]
Vnitrni Lekarstvi
|January 1, 1989
Summary
This study found elevated somatotropic hormone (STH) levels in chronic liver disease patients, particularly those with cirrhosis. STH levels were also analyzed in relation to diabetes and aging in these patients.
Area of Science:
- Endocrinology
- Hepatology
Context:
- Chronic liver disease affects numerous patients globally.
- Altered hormone levels are often observed in liver disease.
- Somatotropic hormone (STH) plays a role in metabolic regulation.
Purpose:
- To investigate somatotropic hormone (STH) levels in patients with chronic liver disease.
- To explore the relationship between STH, liver function, diabetes, and aging.
Summary:
- A study of 114 chronic liver disease patients (1980-1988) measured STH via RIA, alongside bilirubin and liver enzymes.
- Significantly increased STH levels were observed in cirrhosis patients.
- STH levels were generally within or at the upper limit of the reference range for other liver disease diagnoses.
- The study noted a high prevalence of type II diabetes in cirrhosis patients and analyzed STH variations with age.
Impact:
- Highlights potential hormonal dysregulation in chronic liver disease, specifically elevated STH in cirrhosis.
- Suggests a link between STH, liver health, and metabolic conditions like diabetes.
- Provides insights into age-related changes in STH within the context of liver disease.